Evidence map›Paper›PMID 27017828›Full record

ArticleeLife2016

Molecular basis for multimerization in the activation of the epidermal growth factor receptor.

Yongjian Huang, Shashank Bharill, Deepti Karandur, Sean M Peterson, Morgan Marita, Xiaojun Shi, Megan J Kaliszewski, Adam W Smith, Ehud Y Isacoff, John Kuriyan

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 203 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Quantitative Mapping of Nanoscale EGFR-Grb2 Assemblies by DNA-PAINT.Chemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Emergent eukaryotic directional sensing via receptor degradation and diffusion.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Higher-order transient membrane protein structures.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Yongjian HuangDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.
Shashank BharillDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.
Deepti KarandurDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.
Sean M PetersonDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.
Morgan MaritaDepartment of Chemistry, University of Akron, Akron, United States.
Xiaojun ShiDepartment of Chemistry, University of Akron, Akron, United States.
Megan J KaliszewskiDepartment of Chemistry, University of Akron, Akron, United States.
Adam W SmithDepartment of Chemistry, University of Akron, Akron, United States.
Ehud Y IsacoffDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.ORCID 0000-0003-4775-9359
John KuriyanDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.ORCID 0000-0002-4414-5477
QB3 · USUniversity of Akron · USUniversity of California, Berkeley · US

Funding

Engineered Antibody EGFR Antagonist Cancer TherapeuticsR01CA096504 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WITTRUP, KARL DANE · 2002 to 2017
$9.7M
Voltage Gating MechanismsR01GM117051 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI ISACOFF, EHUD · 2016 to 2019
$1.3M
Spatial Organization and Molecular Interactions of Visual OpsinsR15EY024451 · NEI · UNIVERSITY OF AKRON · PI SMITH, ADAM W. · 2015 to 2015
$441k
NCI NIH HHS R01 CA096504NEI NIH HHS R15 EY024451NIGMS NIH HHS R01 GM117051
6 · The paper itself

Abstract

The epidermal growth factor receptor (EGFR) is activated by dimerization, but activation also generates higher-order multimers, whose nature and function are poorly understood. We have characterized ligand-induced dimerization and multimerization of EGFR using single-molecule analysis, and show that multimerization can be blocked by mutations in a specific region of Domain IV of the extracellular module. These mutations reduce autophosphorylation of the C-terminal tail of EGFR and attenuate phosphorylation of phosphatidyl inositol 3-kinase, which is recruited by EGFR. The catalytic activity of EGFR is switched on through allosteric activation of one kinase domain by another, and we show that if this is restricted to dimers, then sites in the tail that are proximal to the kinase domain are phosphorylated in only one subunit. We propose a structural model for EGFR multimerization through self-association of ligand-bound dimers, in which the majority of kinase domains are activated cooperatively, thereby boosting tail phosphorylation.

Indexed as

Protein MultimerizationAllosteric RegulationAnimalsDNA Mutational AnalysisErbB ReceptorsMutant ProteinsOocytesPhosphatidylinositol 3-KinasePhosphorylationProtein Processing, Post-TranslationalSingle Molecule ImagingXenopusEGFR protein, humanErbB ReceptorsMutant ProteinsPhosphatidylinositol 3-KinasebiochemistrybiophysicsEGFRhumanmultimerizationstoichiometrystructural biologyxenopus

Identifiers

PMID27017828
PMCPMC4902571
OpenAlexW2325657998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.